Year: 2018
Type: article
Abstract: in intermediate-stage HCC, a real cure for HCC may cease to be a dream.In fact, clinical trials of combination therapy with lenvatinib and pembrolizumab for HCC have already started (Fig. 9), leaving little doubt that the landscape of HCC treatment will undergo drastic changes in years to come.
Source: Liver Cancer
DOI: 10.1159/000487148
Author: Masatoshi Kudo
Institutions: Kindai University Hospital, Kindai University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,590
OpenAlex ID: W2789297669
